A breast cancer diagnosis is life-changing; many people facing this diagnosis look to gather as much information about their prognosis and treatment options as possible. We know it’s not enough for us to simply develop breakthrough medicines. We must help patients understand cancer and cancer care to help them navigate the decisions they are facing.
We’re proud to announce that after a comprehensive search, Pfizer’s current Chief Oncology Officer and Executive Vice President, Dr. Chris Boshoff, M.D., Ph.D., has been appointed as Pfizer’s Chief Scientific Officer and President, Research & Development, effective January 1, 2025.
Despite advancements in technology that allow for broader reach and easier access to healthcare for people all over the globe, disparities in care remain a challenge, especially for women, diverse populations, and those in more rural areas.
“We’re in a moment of unprecedented progress, an ever-expanding movement to achieve racial and health equity,” stated Dr. Gail Christopher, Executive Director of the National Collaborative for Health Equity, as she kicked off her keynote at the second Health Equity in Action Summit: Communities Forward.
In celebration of National Hispanic Heritage Month (September 15 through October 15 of 2024), Pfizer’s Latino Community Colleague Resource Group holds its annual Latino Summit.